Global Molecular Cytogenetics Market Analysis, Drivers, Restraints, Opportunities, Threats, Trends, Applications, and Growth Forecast: 2019–2028
- Request Covid Impact
- Table of Content
- List of Companies
- Inquiry Before Buying
- Request for Customization
“Global Molecular Cytogenetics Market Analysis Trends, Applications, Analysis, Growth, and Forecast to 2028” is a recent report generated by MarketResearch.biz. The global molecular cytogenetics market report has been segmented as per product type, technique type, end-user, application, and region.
Global Molecular Cytogenetics Market: Overview
Molecular cytogenetics includes all aspects of various applications of chromosome biology and molecular cytogenetic techniques in a wide range of medicine and biology. This includes the functional and structural organization of the nucleus and chromosome, expression and evolution, genome variation, and chromosome abnormalities mainly in tumor genetics and medical genetics. Molecular cytogenetics is a beneficial method for the treatment and diagnosis of various malignant tumors such as brain tumors, cancer, hematological malignancies, etc. The molecular cytogenetics is very important applications in the fields of medicine and biology.
Global Molecular Cytogenetics Market: Dynamics
Rising prevalence of cancer, the subsequent requirement for the accurate diagnosis, and the increasing necessity for the development of advanced technologies for a comprehensive understanding of cancer at a genomic level across the globe. These aforesaid are some major factors forecasted to drive growth of the target market over the forecast period. In addition, rising preference for various cytogenetic techniques among healthcare sector such as Comparative Genomic Hybridization (CGH), Fluorescence in Situ Hybridization (FISH), and others as they provide detailed information about cancer-related molecular signatures. This is a key factor projected to fuel the global molecular cytogenetics market growth during the forecast period.
Increasing adoption of various cytogenetic tools for pharmacogenomic biomarker studies and increasing technological advancements in FISH and CGH techniques are other factors expected to boost growth of the global market. In addition, increasing penetration of various molecular cytogenetics products such as consumables, software and services, instruments, and reagents and kits across the globe is key factor projected to propel growth of the global molecular cytogenetics market.
However, lack of coverage and reimbursement policies for genomic tools in the personalized care application is key factor forecasted to hamper growth of the global molecular cytogenetics market. In addition, less availability of skilled professionals across the globe and high cost associated with the molecular cytogenetic techniques are challenging factors that may affect growth of the target market.
Global Molecular Cytogenetics Market: Segment Analysis
Increasing preference for effective molecular cytogenetic techniques for thorough cancer studies is the primary factor driving revenue growth of the oncology segment among the application segments.
Among the end-user segment, the clinical and research laboratories segment is projected to witness the highest growth in the global molecular cytogenetics market, owing to rising implementation of molecular cytogenetic techniques in clinical discovery.
Global Molecular Cytogenetics Market: Region Analysis
The North America molecular cytogenetics market contributes the largest market share in terms of revenue in the global market, owing to the high presence of research and academic institutes and clinical research laboratories in the countries such as Canada and US in this region. The market in the Asia Pacific is projected to register the fastest growth in the global market followed by the market in Europe, owing to high healthcare expenditure, rising number of scientific researches, and high awareness about advanced therapies and diagnostics in many countries in these regions. The market in Latin America and Middle East & Africa are forecasted to witness steady growth in the global market, owing to rising new players in the countries in these regions..
Global Molecular Cytogenetics Market Segmentation:
Segmentation by Product Type:
- Reagents and Kits
- Software & Services
Segmentation by Technique Type:
- Fluorescence in Situ Hybridization (FISH)
- Comparative Genomic Hybridization (CGH)
- Array-based comparative genomic hybridization
- Standard comparative genomic hybridization
Segmentation by End-user:
- Clinical and Research Laboratories
- Pharmaceutical and Biotechnology Companies
- Research and Academic Institutes
- Diagnostic Centers
Segmentation by Application:
- Genetic Disorders
- Personalized Medicine
Segmentation by Region:
- North America
- Asia Pacific
- Latin America
- Middle East & Africa
Particular Scope Region
- North America
- Rest of Europe
- Asia Pacific
- South Korea
- Rest of Asia Pacific
- Latin America
- Rest of Latin America
- Middle East and Africa
- South Africa
- Rest of Middle East and Africa
Actual Year 2020 Estimated Year 2021 Forecast Period 2021–2030 Revenue in US$
- Danaher Corporation
- BioView Ltd.
- PerkinElmer, Inc.
- Abbott Laboratories
- Oxford Gene Technology IP Limited
- Agilent Technologies, Inc.
- Applied Spectral Imaging Ltd.
- Bio-Rad Laboratories, Inc.
- Hoffmann-La Roche Ltd.
- Quest Diagnostics Incorporated
Request for TOC
Don't just take our word. We are trusted by these great companies!